相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
Alastair M. Thompson et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer
Vincent O. Dezentje et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study
Catherine M. Kelly et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Patient Adherence and Persistence With Oral Anticancer Treatment
Kathryn Ruddy et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
No Increase in Breast Cancer Recurrence with Concurrent Use of Tamoxifen and Some CYP2D6-Inhibiting Medications
Thomas P. Ahern et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Relationship Between Potentially Modifiable Lifestyle Factors and Risk of Second Primary Contralateral Breast Cancer Among Women Diagnosed With Estrogen Receptor-Positive Invasive Breast Cancer
Christopher I. Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Adjuvant Hormonal Therapy Use Among Insured, Low-Income Women With Breast Cancer
Gretchen Kimmick et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Influence of Socioeconomic Disparities on Breast Cancer Tumor Biology and Prognosis: A Review
Linda Vona-Davis et al.
JOURNAL OF WOMENS HEALTH (2009)
CYP2D6 and tamoxifen: DNA matters in breast cancer
Janelle M. Hoskins et al.
NATURE REVIEWS CANCER (2009)
Physical activity and breast cancer survival
Adeyemi A. Ogunleye et al.
BREAST CANCER RESEARCH (2009)
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH (2009)
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
C. McCowan et al.
BRITISH JOURNAL OF CANCER (2008)
Limits of observational data in determining outcomes from cancer therapy
Sharon H. Giordano et al.
CANCER (2008)
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
Cynthia Owusu et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: The health, eating, activity, and lifestyle study
Melinda L. Irwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Tamoxifen pharmacogenomics: The role of CYP2D6 as a predictor of drug response
M. P. Goetz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Smoking and survival after breast cancer diagnosis
Michelle D. Holmes et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy
Kristie Long Foley et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients
Lisa K. Dunnwald et al.
BREAST CANCER RESEARCH (2007)
Racial Differences in Patterns of Care Among Medicaid-Enrolled Patients With Breast Cancer
Gretchen Kimmick et al.
JOURNAL OF ONCOLOGY PRACTICE (2006)
Adherence to tamoxifen over the five-year course
Timothy L. Lash et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Interethnic differences in genetic polymorphisms of CYP2D6 in the US population: Clinical implications
Stephen Bernard et al.
ONCOLOGIST (2006)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Adherence beliefs among breast cancer patients taking tamoxifen
EA Grunfeld et al.
PATIENT EDUCATION AND COUNSELING (2005)
Estrogen receptor-positive, progesterone receptor-negative breast cancer: Association with growth factor receptor expression and tamoxifen resistance
G Arpino et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17
PE Goss et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial
R Jakesz et al.
LANCET (2005)
Drug therapy - Adherence to medication
L Osterberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial
F Boccardo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004
EP Winer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment
Y Jin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
RC Coombes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
AK Fink et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer
PE Goss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
VJ Bardou et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
AH Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane
AU Buzdar et al.
CANCER (2002)
Weight loss in breast cancer patient management
RT Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
S Demissie et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
分享论文
